- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01422577
Diagnosis of Colonic Adenomas by Bright Narrow Band Imaging (B-NBI)
A Randomized Comparison Between White Light Endoscopy (WLE) and Bright Narrow Band Imaging (B-NBI) in the Diagnosis of Colonic Adenomas in Asymptomatic Subjects Undergoing Screening Colonoscopy
Early detection of colo-rectal adenoma using colonoscopy can prevent occurrence of colon cancers. While colonoscopy is a standard technique, it can miss early cancers. To improve the detection rate, Narrow Band Imaging (NBI) was introduced in 2006. It has been shown to compare favorably with chromo-endoscopy in the sensitivity and specificity in the diagnosis of malignant colo-rectal neoplasms. The major drawback of NBI is that images become dark in the presence of blood and fecal matters. The bright-NBI is a prototype imaging technology that enables endoscopists to obtain better images in suboptimal conditions. The study proposes to compare the performance of colonoscopy using either white light or bright NBI in subjects undergoing screening colonoscopy in search for colon adenomas.
Purpose
To determine that bright -NBI is superior to WLE in detecting colorectal adenomas in average risk subjects undergoing screening colonoscopy.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Removal of colorectal adenomas prevents occurrence of cancers [1]. It is recognized that colonoscopy can miss colorectal adenomas and early cancers [2]. There is a need to further improve performance of colonoscopy. The use of chromo-endoscopy has been shown to improve detection of flat adenomas [3]. Narrow band imaging was introduced in year 2006. It is similar to chromo-endoscopy in that it provides more mucosal details. This enables endoscopists to accurately describe the pit pattern of adenomas. NBI has been used as a substitute to chromo-endoscopy. In pooled analysis, NBI is comparable to chromo-endoscopy in their sensitivity and specificity in the diagnosis of malignant colorectal adenomas [4]. Unfortunately, the use of NBI has not been shown to conclusively improve rate of colorectal adenoma detection. Two of 3 randomized trials that compared WLE to NBI showed a higher adenoma detection rate with the use of NBI [5, 6]. In a study by Rex et al., the rate was however similar with either modality. In a pooled analysis, NBI was only marginally better than WLE [4].
The effective use of NBI depends on the quality of bowel preparation and the experience of endoscopist. In the presence of fecal matters, NBI tends to be dark and detection of small adenomas becomes difficult. The prototype bright NBI coupled with high definition resolution is likely to overcome this drawback of original NBI.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Hong Kong, China
- Prince of Wales Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Asymptomatic subjects undergoing screening colonoscopy
- age > 40
- average risk subjects defined as those without a personal history of inflammatory bowel disease, colon adenoma or cancer or family history of Familial adenomatous polyposis (FAP) or Familial non-polyposis syndrome or first degree relatives having diagnosed to have colo-rectal carcinoma
- no colonoscopy in past 5 years
- ability to provide a written consent to trial participation
Exclusion Criteria:
- Patient age < 50
- Patients with prior colorectal surgery
- Pregnant or lactating women
- Colonoscopy done within the past 5 years
- Lack of consent
Study Plan
How is the study designed?
Design Details
- Primary Purpose: DIAGNOSTIC
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
ACTIVE_COMPARATOR: Bright Narrow Band Imaging
|
It is a High Definition system with narrow band imaging option in th endoscope.
|
ACTIVE_COMPARATOR: White Light Endoscopy
|
White light Endoscopy
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Colorectal adenoma detection rate
Time Frame: 2 years
|
compare the rate in colorectal adenoma detection between B-NBI and conventional colonoscopy
|
2 years
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
1. Rate in the detection of advanced neoplasms (defined by adenomas >10 mm in size, with high grade dysplasia or with >25% villous features).
Time Frame: 2 years
|
compare the advanced neoplasm detection rate
|
2 years
|
2. Sensitivity and specificity of either image modality in the diagnosis of malignant adenomas using pathology
Time Frame: 2 years
|
compare the sensitivity and specificity between B-NBI and conventional colonoscopy
|
2 years
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: James YW LAU, MD, Chinese University of Hong Kong
Study record dates
Study Major Dates
Study Start
Primary Completion (ACTUAL)
Study Completion (ACTUAL)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ESTIMATE)
Study Record Updates
Last Update Posted (ESTIMATE)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- B-NBI
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Colonic Adenomas
-
Valduce HospitalIstituti Ospitalieri di Cremona; Istituto Clinico Humanitas; Nuovo Regina Margherita...UnknownColonic AdenomasItaly
-
Martin-Luther-Universität Halle-WittenbergUniversity of Ulm; Deutsche Krebshilfe e.V., Bonn (Germany); KKS NetzwerkCompletedColorectal Serrated Adenomas | Colorectal Tubular Adenomas | Colorectal Villous Adenomas | Colorectal Tubulovillous AdenomasGermany
-
Professor Michael BourkeActive, not recruiting
-
Valduce HospitalUnknown
-
Professor Michael BourkeCompleted
-
Changhai HospitalWuhan Union Hospital, China; Wenzhou Central Hospital; The First Affiliated Hospital...RecruitingColonic Polyps | Colorectal AdenomasChina
-
Genomictree, Inc.Samsung Medical Center; Pusan National University Hospital; Asan Medical Center; Seoul National University Hospital and other collaboratorsRecruitingColorectal Cancer | Advanced Colorectal Neoplasm | Advanced Adenomas | Non-neoplastic Polyps | Non-advanced AdenomasKorea, Republic of
-
PeerMedical Ltd.CompletedColon Cancer | Colon Adenomas | Colon Polyps | Colon DiseasesIsrael
-
Pathway GenomicsCompletedColon Cancer | Colon Adenomas | Colon PolypsUnited States
-
London North West Healthcare NHS TrustCompletedColonic Neoplasms | Colo-rectal Cancer | Colon Adenoma | Adenomas SerratedUnited Kingdom
Clinical Trials on Bright Narrow Band Imaging
-
Professor Michael BourkeActive, not recruiting
-
Mercy Medical CenterAdvocate Lutheran General Hospital; Olympus America, Inc.CompletedEndometriosisUnited States
-
Memorial Sloan Kettering Cancer CenterCompletedOvarian Cancer | Fallopian Tube Cancer | Lung Cancer | Endometrial Cancer | Peritoneal Cancer | Esophageal Carcinoma | Pancreatic Carcinoma | Gastrointestinal CarcinomaUnited States
-
London North West Healthcare NHS TrustUnknown
-
Soonchunhyang University HospitalCompletedGastric Intestinal Metaplasia | Narrow-band Imaging | Magnifying EndoscopyKorea, Republic of
-
London North West Healthcare NHS TrustNottingham University Hospitals NHS TrustUnknownUlcerative ColitisUnited Kingdom
-
Imperial College LondonCompleted
-
Soonchunhyang University HospitalCompleted
-
King's College Hospital NHS TrustOlympusCompletedCeliac DiseaseUnited Kingdom